SHE:002821 - Asymchem Laboratories Tianjin Co Ltd

Asymchem Laboratories Tian Jin
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q4	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	7.7B 5.7%	8.43B 9.5%	15.16B 79.8%	16.39B 8.1%	17.83B 8.8%	18.06B 1.3%	18.24B 1.0%	18.55B 1.7%	19.2B 3.5%	19.76B 3.0%	19.77B 0.0%	19.84B 0.4%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.05B 1.3%	4.25B 4.9%	10.31B 142.8%	11.06B 7.3%	12.1B 9.4%	12.18B 0.6%	11.86B -2.6%	11.98B 1.0%	12.62B 5.4%	13.06B 3.5%	12.35B -5.4%	12.11B -2.0%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.03B 2.0%	1.52B -25.0%	6.64B 335.1%	6.53B -1.6%	6.68B 2.3%	7.69B 15.0%	7.44B -3.2%	8.41B 13.0%	8.9B 5.8%	9.2B 3.4%	9.02B -2.1%	8.98B -0.4%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.65B 11.0%	4.19B 14.7%	4.85B 15.8%	5.33B 10.0%	5.73B 7.5%	5.89B 2.7%	6.38B 8.4%	6.57B 3.0%	6.58B 0.1%	6.71B 1.9%	7.42B 10.6%	7.73B 4.3%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.41B 24.9%	1.85B 31.3%	2.55B 37.6%	2.88B 12.9%	3.25B 12.9%	3B -7.6%	2.54B -15.3%	2.18B -14.4%	2.4B 10.5%	2.29B -4.7%	2.26B -1.5%	2.23B -1.0%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.1B 25.7%	1.53B 39.4%	2.2B 44.0%	2.49B 13.0%	2.83B 13.6%	2.59B -8.5%	2.18B -15.9%	1.77B -18.5%	1.98B 11.5%	1.79B -9.2%	1.8B 0.3%	1.77B -1.8%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	311.5M 22.3%	320.33M 2.8%	341.48M 6.6%	384.07M 12.5%	416.83M 8.5%	413.3M -0.8%	367.18M -11.2%	403.44M 9.9%	427.76M 6.0%	497.45M 16.3%	456.38M -8.3%	466.22M 2.2%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.29B 2.1%	6.58B 4.7%	12.61B 91.6%	13.51B 7.2%	14.59B 7.9%	15.06B 3.3%	15.7B 4.2%	16.37B 4.3%	16.79B 2.6%	17.47B 4.0%	17.51B 0.2%	17.61B 0.6%
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.29B 2.1%	6.58B 4.7%	12.61B 91.6%	13.51B 7.2%	14.59B 7.9%	15.06B 3.3%	15.65B 3.9%	16.32B 4.3%	16.75B 2.6%	17.43B 4.1%	17.48B 0.3%	17.58B 0.6%
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-42.38K -	-53.72K -	0 -	-	-	0 -	47.58M -	45.12M -5.2%	43.2M -4.3%	38.28M -11.4%	30.26M -20.9%	28.05M -7.3%